Scientists have shown how tumor cells evade immunotherapy by generating unique, temporary cell-in-cell structures, where the inner cells remain in tact and can return to single tumor cells.
Sep 20, 2022
0
15
DNA damage is one of the foundational causes of cancer. But researchers have now found that deliberately causing DNA damage—by delivering additional treatments like radiotherapy—could improve the effectiveness of immunotherapy ...
Sep 20, 2022
0
71
Patients with advanced lung cancer had a better chance at survival when their treatment combined chemotherapy with a drug designed to turn the immune system against cancer, according to two studies released Sunday at a conference ...
Sep 12, 2022
0
9
A University of Cincinnati study found administering an immunotherapy drug before surgery for oral cavity cancer did not lead to increased rates of complications during and after surgery.
Sep 7, 2022
0
10
Researchers have discovered that some immunotherapy treatments used to treat cancer can cause fertility damage.
Aug 26, 2022
0
49
Stimulator of interferon genes, or STING, helps regulate immune activation. Thus, a research team is testing drugs that activate STING as a form of cancer immunotherapy and for treating certain infections. Findings from ...
Aug 10, 2022
0
37
Sometimes too much of a good thing is not good at all. Inhibiting the function of the PD-1 protein, which blocks immune function, has shown high therapeutic efficacy in cancer immunotherapy. However, when this function is ...
Aug 9, 2022
0
2
During a battle with cancer, T cells can become exhausted and are no longer able to function properly. The early phase of exhaustion can sometimes be reversed with immunotherapy drugs, but once T cells become too exhausted, ...
Aug 5, 2022
0
501
An epigenetic inhibitor can boost immune system activity in patients with ovarian cancer, making them more suitable for treatment with immunotherapy, according to a Northwestern Medicine study published in the Journal of ...
Jul 26, 2022
0
69
A new research paper was published in Oncotarget on July 19, 2022, titled "Predicting cancer immunotherapy response from gut microbiomes using machine learning models."
Jul 19, 2022
0
9
